Mar 17 2018
On March 13, 2018. Precision BioLogic Inc., Dartmouth, NS, announced their development of a new approach to standardize and improve factor VIII inhibitor testing. Their press release (tap or click) referenced new data presented in a poster at the Thrombosis and Hemostasis Societies of North America, March 8–10, 2018 meeting, in San Diego, CA, USA. More information is also available on the Precision BioLogic Inc. web site publications list.
Comments (0)
Bleeding Disorders
No comments here.